|
Chuck is responsible for managing assay development and validation of immunochemical techniques for both nonclinical and clinical projects involving protein drugs, biomarkers, and antibodies.Chuck brings more than 10 years of pharmaceutical industry experience in research and development. Prior to joining MBR, he was at Pfizer/Pharmacia and Searle/Monsanto, where he developed and validated immunoassays for detecting drug candidates in support of drug discovery and development projects, using automated instrumentation to maintain high throughput for rapid sample turnaround.Chuck received a B.S. degree in biology from the University of Illinois, Chicago. Chuck also earned a medical technology degree from Holy Cross Hospital, Chicago. | 